Bifogade filer
Kurs
+0,80%
Kalender
Est. tid* | ||
2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-08-21 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-15 | - | X-dag ordinarie utdelning ARCOMA 0.00 SEK |
2025-05-14 | - | Årsstämma |
2025-04-29 | - | Kvartalsrapport 2025-Q1 |
2025-02-13 | - | Bokslutskommuniké 2024 |
2024-10-24 | - | Kvartalsrapport 2024-Q3 |
2024-08-15 | - | Kvartalsrapport 2024-Q2 |
2024-05-17 | - | X-dag ordinarie utdelning ARCOMA 0.00 SEK |
2024-05-15 | - | Årsstämma |
2024-04-25 | - | Kvartalsrapport 2024-Q1 |
2024-01-29 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-08-17 | - | Kvartalsrapport 2023-Q2 |
2023-05-19 | - | X-dag ordinarie utdelning ARCOMA 0.00 SEK |
2023-05-17 | - | Årsstämma |
2023-04-27 | - | Kvartalsrapport 2023-Q1 |
2023-02-09 | - | Bokslutskommuniké 2022 |
2022-11-18 | - | Extra Bolagsstämma 2022 |
2022-10-27 | - | Kvartalsrapport 2022-Q3 |
2022-08-17 | - | Kvartalsrapport 2022-Q2 |
2022-05-19 | - | X-dag ordinarie utdelning ARCOMA 0.00 SEK |
2022-05-18 | - | Årsstämma |
2022-04-28 | - | Kvartalsrapport 2022-Q1 |
2022-02-10 | - | Bokslutskommuniké 2021 |
2021-10-28 | - | Kvartalsrapport 2021-Q3 |
2021-08-25 | - | Kvartalsrapport 2021-Q2 |
2021-05-26 | - | X-dag ordinarie utdelning ARCOMA 0.00 SEK |
2021-05-25 | - | Årsstämma |
2021-05-24 | - | Kvartalsrapport 2021-Q1 |
2021-02-18 | - | Bokslutskommuniké 2020 |
2020-11-12 | - | Kvartalsrapport 2020-Q3 |
2020-08-20 | - | Kvartalsrapport 2020-Q2 |
2020-05-22 | - | X-dag ordinarie utdelning ARCOMA 0.00 SEK |
2020-05-20 | - | Årsstämma |
2020-05-20 | - | Kvartalsrapport 2020-Q1 |
2020-02-21 | - | Bokslutskommuniké 2019 |
2019-11-19 | - | Kvartalsrapport 2019-Q3 |
2019-08-22 | - | Kvartalsrapport 2019-Q2 |
2019-05-24 | - | X-dag ordinarie utdelning ARCOMA 0.00 SEK |
2019-05-23 | - | Årsstämma |
2019-05-23 | - | Kvartalsrapport 2019-Q1 |
2019-02-22 | - | Bokslutskommuniké 2018 |
2018-11-22 | - | Kvartalsrapport 2018-Q3 |
2018-08-22 | - | Kvartalsrapport 2018-Q2 |
2018-05-25 | - | X-dag ordinarie utdelning ARCOMA 0.00 SEK |
2018-05-24 | - | Årsstämma |
2018-05-24 | - | Kvartalsrapport 2018-Q1 |
2018-02-23 | - | Bokslutskommuniké 2017 |
2017-11-24 | - | Kvartalsrapport 2017-Q3 |
2017-08-18 | - | Kvartalsrapport 2017-Q2 |
2017-05-18 | - | Årsstämma |
2017-05-18 | - | Kvartalsrapport 2017-Q1 |
2017-05-17 | - | X-dag ordinarie utdelning ARCOMA 0.00 SEK |
2017-02-24 | - | Bokslutskommuniké 2016 |
2017-01-19 | - | Extra Bolagsstämma 2017 |
2016-11-25 | - | Kvartalsrapport 2016-Q3 |
2016-08-31 | - | Kvartalsrapport 2016-Q2 |
2016-05-23 | - | X-dag ordinarie utdelning ARCOMA 0.00 SEK |
2016-05-20 | - | Årsstämma |
2016-05-20 | - | Kvartalsrapport 2016-Q1 |
2016-02-24 | - | Bokslutskommuniké 2015 |
2015-11-25 | - | Kvartalsrapport 2015-Q3 |
2015-11-24 | - | Kvartalsrapport 2015-Q3 |
2015-08-31 | - | Kvartalsrapport 2015-Q2 |
2015-05-20 | - | X-dag ordinarie utdelning ARCOMA 0.00 SEK |
2015-05-19 | - | Årsstämma |
2015-05-19 | - | Kvartalsrapport 2015-Q1 |
2015-02-19 | - | Bokslutskommuniké 2014 |
2014-11-19 | - | Kvartalsrapport 2014-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
2021-06-10
PRESSRELEASE
Arcoma receives first order on the new product, OMNERA 500A
Arcoma AB has received the first order on the new product OMNERA 500A.
The OMNERA 500A is a new X-ray system developed with focus on efficient workflow, safety and ease of use. The ergonomic design simplifies and optimizes positioning and has been carefully designed to facilitate disinfection. OMNERA 500A is equipped with the latest touch screen technology and a new user interface which creates simplicity and efficiency for the user. A new wall stand with motorized tilt simplifies positioning and an updated X-ray table improves patient and user experience.
The order is placed by Canon Medical systems USA, Arcoma's partner in the US and will be delivered in June 2021.
"It feels great to start sales of our new product OMNERA 500A in the US market. The US is a large, important and central market in our continued growth. We are now looking forward to growing the business together with our partner Canon Medical Systems USA" , says Sanna Rydberg, CEO of Arcoma AB.
About Canon Medical Systems USA
Canon Medical Systems USA, Inc., headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment. For more information, visit Canon Medical Systems’ website at https://us.medical.canon.
About Canon Medical Systems Corporation
Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-Ray, Ultrasound, Vascular and MR, as well as a full suite of Healthcare IT solutions, across the globe. In line with our continued Made for Life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features. For more information, visit the Canon Medical website: https://global.medical.canon.
OMNERA is a registered trademark of CANON MEDICAL SYSTEMS USA, INC. Made for Life is a trademark of Canon Medical Systems Corporation. CXDI is registered trademarks of Canon in the United States and may also be registered trademarks or trademarks in other countries.
About Arcoma
Arcoma, with long experience in the industry, is a leading provider of integrated digital X-ray systems with high quality and advanced technology. Arcoma’s products offer the latest digital imaging technology combined with technically advanced moving positioning systems and ergonomic Scandinavian design. Arcoma offers the customers complete, configurable and functional digital x-ray systems. The company's products are sold through retailers as well as OEM customers and today there are over 3,500 of Arcoma’s X-ray systems installed worldwide. Arcoma is listed on Nasdaq First North. For more information about Arcoma, please visit www.arcoma.se
For more information, please contact:
Sanna Rydberg, Telefon: +46 706 069548, E-mail: sanna.rydberg@arcoma.se. The information was submitted, through the CEO, for publication on June 10, 2021 at 10 AM.
For more IR-related information and the possibility of pressrelease prenumeration, please visit our IR page: www.arcoma.se/about-us/investors/